Skip to main content
Log in

Response to van Saene et al.'s comment on "Prevention of severe Candida infections in non-neutropenic, high-risk, critically ill patients"

  • Correspondence
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Garbino J, Lew, D. P, Romand, J.-A, Hugonnet S, Auckenthaler R, Pittet D (2002) Prevention of severe Candida infections in non-neutropenic, high-risk, critically ill patients. A randomized, double-blind, placebo-controlled trial in SDD-treated patients. Intensive Care Med 28:1708–1717

    Article  PubMed  Google Scholar 

  2. Saene HKF van, Silvestri L, Petros A, Viviani M, de la Cal MA, Zandstra DF (2003) Comment on "Prevention of severe Candida infections in non-neutropenic, high-risk, critically ill patients." Intensive Care Med (http://dx.doi.org/10.1007/s00134-003-1770-7)

  3. Slotman GJ, Burchard KW (1987) Ketoconazole prevents Candida sepsis in critically ill surgical patients. Arch Surg 122:147–151

    CAS  PubMed  Google Scholar 

  4. Savino JA, Agarwal N, Wry P, Policastro A, Cerabona T, Austria L (1994) Routine prophylactic antifungal agents (clotrimazole, ketoconazole, and nystatin) in nontransplant/nonburned critically ill surgical and trauma patients. J Trauma 36:20–26

    CAS  PubMed  Google Scholar 

  5. Eggimann P, Francioli P, Bille J, Schneider R, Wu MM, Chapuis G, Chiolero R, Pannatier A, Schilling J, Geroulanos S, Glauser MP, Calandra T (1999) Fluconazole prophylaxis of intra-abdominal candidiasis in high-risk surgical patients: a double-blind, placebo-controlled study. Crit Care Med 27:1066–1072

    CAS  PubMed  Google Scholar 

  6. Pelz RK, Hendrix CW, Swoboda SM, Diener-West M, Merz WG, Hammond J, Lipsett PA (2001) Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg 233:542–548

    CAS  PubMed  Google Scholar 

  7. Philpott-Howard JN, Wade JJ, Mufti GJ, Brammer KW, Ehninger G, for the Multicentre Study Group (1993) Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. J Antimicrob Chemother 31:973–984

    CAS  PubMed  Google Scholar 

  8. Lumbreras C, Cuervas-Mons V, Jara P, del Palacio A, Turrión VS, Barrios C, Moreno E, Noriega AR, Paya CV (1996) Randomized trial of fluconazole versus nystatin for the prophylaxis of Candida infection following liver transplantation. J Infect Dis 174:583–588

    CAS  PubMed  Google Scholar 

  9. De Pauw BE (1997) Practical modalities for prevention of fungal infections in cancer patients. Eur J Clin Microbiol Infect Dis 16:32–41

    PubMed  Google Scholar 

  10. Rex JH, Sobel JD (2001) Prophylactic antifungal therapy in the intensive care unit. Clin Infect Dis 32:1191–1200

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Thierry Calandra.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Calandra, T., Marchetti, O. Response to van Saene et al.'s comment on "Prevention of severe Candida infections in non-neutropenic, high-risk, critically ill patients". Intensive Care Med 29, 1196 (2003). https://doi.org/10.1007/s00134-003-1842-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-003-1842-8

Keywords

Navigation